Oncogenesis - Table of Contents alert Volume 3 December 2014

Advertisement CRISPR/Cas9 monoclonal antibody now available Diagenode now offers the first monoclonal antibody against CRISPR/Cas9 Better performance that tag antibodies Validated for all major applications such as immunoblot, immunoprecipitation, and IF Recognizes Cas9 and dCas9 Learn more TABLE OF CONTENTS Volume 3, December 2014 In this issue Editorial Original Articles Sign up for e-alerts Web feed Advertisement Nature Reviews Clinical Oncology  Focus on Paediatric cancer Paediatric oncology is a bustling field with a wide remit, from genomic studies to surgical innovations. This Focus issue aims to look at a number of the key issues, and the cutting-edge research, surrounding treating arguably our most vulnerable patients. Produced with support of a grant from Bristol-Myers Squibb Editorial Top Welcome to the next step for Oncogenesis J P Medema Oncogenesis 2014 3: e130; 10.1038/oncsis.2014.46 Full Text Original Articles Top Regulation of CDX4 gene transcription by HoxA9, HoxA10, the Mll-Ell oncogene and Shp2 during leukemogenesis L Bei, C Shah, H Wang, W Huang, L C Platanias and E A Eklund Oncogenesis 2014 3: e135; 10.1038/oncsis.2014.49 Abstract | Full Text Kinome-wide screening of HER2+ breast cancer cells for molecules that mediate cell proliferation or sensitize cells to trastuzumab therapy V Lapin, E A Shirdel, X Wei, J M Mason, I Jurisica and T W Mak Oncogenesis 2014 3: e133; 10.1038/oncsis.2014.45 Abstract | Full Text DNA damage signaling guards against perturbation of cyclin D1 expression triggered by low-dose long-term fractionated radiation T Shimura, J Kobayashi, K Komatsu and N Kunugita Oncogenesis 2014 3: e132; 10.1038/oncsis.2014.48 Abstract | Full Text SUV39H1/H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells G W Watson, S Wickramasekara, Z Palomera-Sanchez, C Black, C S Maier, D E Williams, R H Dashwood and E Ho Oncogenesis 2014 3: e131; 10.1038/oncsis.2014.47 Abstract | Full Text Advertisement Nature Collections Clinical applications of next-generation sequencing Produced with support from  Life Technologies, a brand of Thermo Fisher Scientific.    Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.